{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:58:36Z","timestamp":1792547916662,"version":"4.5.0"},"reference-count":154,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.neurol.2015.07.011","type":"journal-article","created":{"date-parts":[[2015,9,4]],"date-time":"2015-09-04T12:11:44Z","timestamp":1441368704000},"page":"750-761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Animal models of Parkinson's disease: An updated overview"],"prefix":"10.1016","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4668-9136","authenticated-orcid":false,"given":"P.","family":"Gubellini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Kachidian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neurol.2015.07.011_bib0005","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl. 17","key":"10.1016\/j.neurol.2015.07.011_bib0010","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1002\/mds.21675","article-title":"The pathogenesis of cell death in Parkinson's disease","volume":"22","author":"Olanow","year":"2007","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.neurol.2015.07.011_bib0015","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.parkreldis.2011.02.018","article-title":"Parkinson's disease: the non-motor issues","volume":"17","author":"Chaudhuri","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"10.1016\/j.neurol.2015.07.011_bib0020","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.tins.2013.06.003","article-title":"Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems","volume":"36","author":"Brichta","year":"2013","journal-title":"Trends Neurosci"},{"issue":"4","key":"10.1016\/j.neurol.2015.07.011_bib0025","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.euroneuro.2005.04.007","article-title":"Prevalence and incidence of Parkinson's disease in Europe","volume":"15","author":"von Campenhausen","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"10.1016\/j.neurol.2015.07.011_bib0030","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol"},{"issue":"Suppl. 1","key":"10.1016\/j.neurol.2015.07.011_bib0035","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1007\/s10198-005-0290-5","article-title":"Economic evidence in Parkinson's disease: a review","volume":"5","author":"Lindgren","year":"2004","journal-title":"Eur J Health Econ"},{"issue":"6","key":"10.1016\/j.neurol.2015.07.011_bib0040","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/mds.23732","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"26","author":"Schapira","year":"2011","journal-title":"Mov Disord"},{"issue":"5646","key":"10.1016\/j.neurol.2015.07.011_bib0045","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","article-title":"Molecular pathways of neurodegeneration in Parkinson's disease","volume":"302","author":"Dawson","year":"2003","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neurol.2015.07.011_bib0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbadis.2009.08.001","article-title":"Downstream mechanisms triggered by mitochondrial dysfunction in the basal ganglia: from experimental models to neurodegenerative diseases","volume":"1802","author":"Gubellini","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.neurol.2015.07.011_bib0055","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/mds.23637","article-title":"Milestones in PD genetics","volume":"26","author":"Gasser","year":"2011","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.neurol.2015.07.011_bib0060","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neurol.2015.07.011_bib0065","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"Ahlskog","year":"2001","journal-title":"Mov Disord"},{"issue":"5 Suppl. 5","key":"10.1016\/j.neurol.2015.07.011_bib0070","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1212\/WNL.50.5_Suppl_5.S17","article-title":"Levodopa therapy: consequences of the nonphysiologic replacement of dopamine","volume":"50","author":"Chase","year":"1998","journal-title":"Neurology"},{"issue":"21 Suppl. 4","key":"10.1016\/j.neurol.2015.07.011_bib0075","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1212\/WNL.0b013e3181a1d44c","article-title":"The scientific and clinical basis for the treatment of Parkinson disease","volume":"72","author":"Olanow","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2015.07.011_bib0080","first-page":"405","article-title":"Deep brain stimulation for Parkinson's disease","volume":"86","author":"Benabid","year":"2001","journal-title":"Adv Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2015.07.011_bib0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(08)70291-6","article-title":"Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease","volume":"8","author":"Benabid","year":"2009","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.neurol.2015.07.011_bib0090","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1460-9568.2010.07416.x","article-title":"A functionally relevant and long-term model of deep brain stimulation of the rat subthalamic nucleus: advantages and considerations","volume":"32","author":"Spieles-Engemann","year":"2010","journal-title":"Eur J Neurosci"},{"issue":"1","key":"10.1016\/j.neurol.2015.07.011_bib0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pneurobio.2009.06.003","article-title":"Deep brain stimulation in neurological diseases and experimental models: from molecule to complex behavior","volume":"89","author":"Gubellini","year":"2009","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neurol.2015.07.011_bib0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/B978-0-12-404706-8.00004-8","article-title":"Neurophysiology of deep brain stimulation","volume":"107","author":"Rosa","year":"2012","journal-title":"Int Rev Neurobiol"},{"issue":"5","key":"10.1016\/j.neurol.2015.07.011_bib0105","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3171\/2013.9.FOCUS13383","article-title":"Deep brain stimulation: a mechanistic and clinical update","volume":"35","author":"Karas","year":"2013","journal-title":"Neurosurg Focus"},{"issue":"1","key":"10.1016\/j.neurol.2015.07.011_bib0110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/npp.2011.212","article-title":"Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa","volume":"37","author":"Smith","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"9942","key":"10.1016\/j.neurol.2015.07.011_bib0115","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(14)61010-2","article-title":"Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives","volume":"384","author":"Schapira","year":"2014","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.neurol.2015.07.011_bib0120","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/cne.23577","article-title":"Treating Parkinson's disease in the 21st century: can stem cell transplantation compete?","volume":"522","author":"Buttery","year":"2014","journal-title":"J Comp Neurol"},{"issue":"3","key":"10.1016\/j.neurol.2015.07.011_bib0125","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex\u00a0I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.neurol.2015.07.011_bib0130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(68)90164-7","article-title":"6-Hydroxy-dopamine induced degeneration of central monoamine neurons","volume":"5","author":"Ungerstedt","year":"1968","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.neurol.2015.07.011_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-2952(75)90304-4","article-title":"Mechanisms of action of 6-hydroxydopamine","volume":"24","author":"Sachs","year":"1975","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neurol.2015.07.011_bib0140","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0022-3565(25)26555-7","article-title":"Effect of 6-hydroxydopamine and some other compounds on the concentration of norepinephrine in the hearts of mice","volume":"140","author":"Porter","year":"1963","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.neurol.2015.07.011_bib0145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease","volume":"65","author":"Blum","year":"2001","journal-title":"Prog Neurobiol"},{"issue":"6","key":"10.1016\/j.neurol.2015.07.011_bib0150","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/j.1460-9568.2006.05047.x","article-title":"Chronic high-frequency stimulation of the subthalamic nucleus and L-DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission","volume":"24","author":"Gubellini","year":"2006","journal-title":"Eur J Neurosci"},{"issue":"3","key":"10.1016\/j.neurol.2015.07.011_bib0155","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","article-title":"Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system","volume":"24","author":"Ungerstedt","year":"1970","journal-title":"Brain Res"},{"issue":"7","key":"10.1016\/j.neurol.2015.07.011_bib0160","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nrn877","article-title":"Animal models of neurological deficits: how relevant is the rat?","volume":"3","author":"Cenci","year":"2002","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"10.1016\/j.neurol.2015.07.011_bib0165","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1523\/JNEUROSCI.07-07-02129.1987","article-title":"Depletion of dopamine in the caudate nucleus but not in nucleus accumbens impairs reaction-time performance in rats","volume":"7","author":"Amalric","year":"1987","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.neurol.2015.07.011_bib0170","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0149-7634(98)00014-1","article-title":"Reaction time deficits and Parkinson's disease","volume":"22","author":"Gauntlett-Gilbert","year":"1998","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neurol.2015.07.011_bib0175","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fnbeh.2014.00290","article-title":"A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions","volume":"8","author":"Bonito-Oliva","year":"2014","journal-title":"Front Behav Neurosci"},{"issue":"3","key":"10.1016\/j.neurol.2015.07.011_bib0180","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0301-0082(96)00015-9","article-title":"Unilateral 6-hydroxydopamine lesions of mesostriatal dopamine neurons and their physiological sequelae","volume":"49","author":"Schwarting","year":"1996","journal-title":"Prog Neurobiol"},{"issue":"Pt 2","key":"10.1016\/j.neurol.2015.07.011_bib0185","first-page":"433","article-title":"Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease","volume":"116","author":"Calabresi","year":"1993","journal-title":"Brain"},{"issue":"16","key":"10.1016\/j.neurol.2015.07.011_bib0190","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1523\/JNEUROSCI.22-16-06900.2002","article-title":"Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission","volume":"22","author":"Gubellini","year":"2002","journal-title":"J Neurosci"},{"issue":"16","key":"10.1016\/j.neurol.2015.07.011_bib0195","doi-asserted-by":"crossref","first-page":"6430","DOI":"10.1523\/JNEUROSCI.21-16-06430.2001","article-title":"Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions","volume":"21","author":"Tseng","year":"2001","journal-title":"J Neurosci"},{"issue":"10 Suppl.","key":"10.1016\/j.neurol.2015.07.011_bib0200","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S1471-1931(00)00017-3","article-title":"Electrophysiology of dopamine in normal and denervated striatal neurons","volume":"23","author":"Calabresi","year":"2000","journal-title":"Trends Neurosci"},{"issue":"42","key":"10.1016\/j.neurol.2015.07.011_bib0205","doi-asserted-by":"crossref","first-page":"14182","DOI":"10.1523\/JNEUROSCI.2149-10.2010","article-title":"Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition","volume":"30","author":"Paill\u00e9","year":"2010","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.neurol.2015.07.011_bib0210","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1046\/j.1471-4159.2003.01759.x","article-title":"Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism","volume":"85","author":"Maccarrone","year":"2003","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.neurol.2015.07.011_bib0215","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","article-title":"Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia","volume":"6","author":"Picconi","year":"2003","journal-title":"Nat Neurosci"},{"issue":"9","key":"10.1016\/j.neurol.2015.07.011_bib0220","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1523\/JNEUROSCI.2949-06.2007","article-title":"High-frequency stimulation of the subthalamic nucleus potentiates L-DOPA-induced neurochemical changes in the striatum in a rat model of Parkinson's disease","volume":"27","author":"Oueslati","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2015.07.011_bib0225","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.coph.2014.11.001","article-title":"Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease","volume":"20","author":"Amalric","year":"2015","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"10.1016\/j.neurol.2015.07.011_bib0230","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.nbd.2011.10.023","article-title":"Emerging dysfunctions consequent to combined monoaminergic depletions in Parkinsonism","volume":"45","author":"Delaville","year":"2012","journal-title":"Neurobiol Dis"},{"issue":"7","key":"10.1016\/j.neurol.2015.07.011_bib0235","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/WNL.35.7.949","article-title":"Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases","volume":"35","author":"Ballard","year":"1985","journal-title":"Neurology"},{"issue":"4587","key":"10.1016\/j.neurol.2015.07.011_bib0240","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neurol.2015.07.011_bib0245","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1749-6632.2003.tb07476.x","article-title":"The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease","volume":"991","author":"Przedborski","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.neurol.2015.07.011_bib0250","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0301-0082(94)90021-3","article-title":"Monoamine oxidase: distribution in the cat brain studied by enzyme- and immunohistochemistry: recent progress","volume":"42","author":"Kitahama","year":"1994","journal-title":"Prog Neurobiol"},{"issue":"1","key":"10.1016\/j.neurol.2015.07.011_bib0255","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/(SICI)1098-2396(199701)25:1<30::AID-SYN4>3.0.CO;2-G","article-title":"Localization of monoamine oxidase\u00a0A and B mRNA in the rat brain by in situ hybridization","volume":"25","author":"Jahng","year":"1997","journal-title":"Synapse"},{"issue":"4","key":"10.1016\/j.neurol.2015.07.011_bib0260","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/cne.10093","article-title":"Developmental expression of monoamine oxidases\u00a0A and B in the central and peripheral nervous systems of the mouse","volume":"442","author":"Vitalis","year":"2002","journal-title":"J Comp Neurol"},{"issue":"2\u20133","key":"10.1016\/j.neurol.2015.07.011_bib0265","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0300-483X(88)90037-6","article-title":"The formation of reactive intermediates in the MAO-catalyzed oxidation of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"49","author":"Trevor","year":"1988","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.neurol.2015.07.011_bib0270","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0300-483X(88)90169-2","article-title":"Mechanism of the neurotoxicity of 1-methyl-4-phenylpyridinium (MPP+), the toxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"49","author":"Singer","year":"1988","journal-title":"Toxicology"},{"issue":"26","key":"10.1016\/j.neurol.2015.07.011_bib0275","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","article-title":"Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine","volume":"36","author":"Nicklas","year":"1985","journal-title":"Life Sci"},{"issue":"17","key":"10.1016\/j.neurol.2015.07.011_bib0280","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.1016\/S0021-9258(19)57434-8","article-title":"Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria","volume":"261","author":"Ramsay","year":"1986","journal-title":"J Biol Chem"},{"issue":"Suppl. 2","key":"10.1016\/j.neurol.2015.07.011_bib0285","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.parkreldis.2008.04.012","article-title":"pathogenesis in mice: advantages of a chronic MPTP protocol","volume":"14","author":"Meredith","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1016\/j.neurol.2015.07.011_bib0290","first-page":"548","article-title":"Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in rat, guinea pig, and monkey","volume":"20","author":"Chiueh","year":"1984","journal-title":"Psychopharmacol Bull"},{"issue":"10","key":"10.1016\/j.neurol.2015.07.011_bib0295","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/mds.21010","article-title":"Behavioral models of Parkinson's disease in rodents: a new look at an old problem","volume":"21","author":"Meredith","year":"2006","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.neurol.2015.07.011_bib0300","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","article-title":"The MPTP model of Parkinson's disease","volume":"134","author":"Smeyne","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neurol.2015.07.011_bib0305","first-page":"600","article-title":"Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations","volume":"60","author":"Forno","year":"1993","journal-title":"Adv Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2015.07.011_bib0310","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0006-8993(02)03514-X","article-title":"Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease","volume":"956","author":"Meredith","year":"2002","journal-title":"Brain Res"},{"issue":"9","key":"10.1016\/j.neurol.2015.07.011_bib0315","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1073\/pnas.0409713102","article-title":"Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein","volume":"102","author":"Fornai","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.neurol.2015.07.011_bib0320","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1152\/jn.1994.72.2.507","article-title":"The primate subthalamic nucleus. II.\u00a0Neuronal activity in the MPTP model of parkinsonism","volume":"72","author":"Bergman","year":"1994","journal-title":"J Neurophysiol"},{"issue":"6","key":"10.1016\/j.neurol.2015.07.011_bib0325","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1046\/j.1460-9568.1999.00627.x","article-title":"Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms","volume":"11","author":"Bezard","year":"1999","journal-title":"Eur J Neurosci"},{"issue":"Pt 10","key":"10.1016\/j.neurol.2015.07.011_bib0330","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1093\/brain\/awh616","article-title":"Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations","volume":"128","author":"Meissner","year":"2005","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2015.07.011_bib0335","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0006-8993(01)02577-X","article-title":"Carrier-mediated processes in blood \u2013 brain barrier penetration and neural uptake of paraquat","volume":"906","author":"Shimizu","year":"2001","journal-title":"Brain Res"},{"issue":"22","key":"10.1016\/j.neurol.2015.07.011_bib0340","doi-asserted-by":"crossref","first-page":"12760","DOI":"10.1073\/pnas.96.22.12760","article-title":"A mechanism of paraquat toxicity involving nitric oxide synthase","volume":"96","author":"Day","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"51","key":"10.1016\/j.neurol.2015.07.011_bib0345","doi-asserted-by":"crossref","first-page":"20766","DOI":"10.1073\/pnas.1115141108","article-title":"Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3","volume":"108","author":"Rappold","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.neurol.2015.07.011_bib0350","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.freeradbiomed.2011.06.034","article-title":"Paraquat induces behavioral changes and cortical and striatal mitochondrial dysfunction","volume":"51","author":"Czerniczyniec","year":"2011","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"10.1016\/j.neurol.2015.07.011_bib0355","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1074\/jbc.M708597200","article-title":"Complex\u00a0I is the major site of mitochondrial superoxide production by paraquat","volume":"283","author":"Cocheme","year":"2008","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.neurol.2015.07.011_bib0360","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/taap.1996.0147","article-title":"Disulfiram and diethyldithiocarbamate intoxication affects the storage and release of striatal dopamine","volume":"139","author":"Vaccari","year":"1996","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"10.1016\/j.neurol.2015.07.011_bib0365","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.neuro.2006.05.012","article-title":"Paraquat exposure as an etiological factor of Parkinson's disease","volume":"27","author":"Dinis-Oliveira","year":"2006","journal-title":"Neurotoxicology"},{"issue":"5","key":"10.1016\/j.neurol.2015.07.011_bib0370","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.neuro.2012.05.011","article-title":"Pesticide exposure and Parkinson's disease: epidemiological evidence of association","volume":"33","author":"Freire","year":"2012","journal-title":"Neurotoxicology"},{"issue":"6","key":"10.1016\/j.neurol.2015.07.011_bib0375","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1460-9568.2005.04301.x","article-title":"A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?","volume":"22","author":"Ossowska","year":"2005","journal-title":"Eur J Neurosci"},{"issue":"4","key":"10.1016\/j.neurol.2015.07.011_bib0380","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.neuroscience.2006.05.039","article-title":"Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: implications for Parkinson's disease","volume":"141","author":"Ossowska","year":"2006","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2015.07.011_bib0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(98)01192-5","article-title":"Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss","volume":"823","author":"Brooks","year":"1999","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.neurol.2015.07.011_bib0390","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/nbdi.2002.0507","article-title":"Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat","volume":"10","author":"McCormack","year":"2002","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.neurol.2015.07.011_bib0395","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1460-9568.2003.02781.x","article-title":"Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype","volume":"18","author":"Thiruchelvam","year":"2003","journal-title":"Eur J Neurosci"},{"issue":"1","key":"10.1016\/j.neurol.2015.07.011_bib0400","first-page":"167","article-title":"Maneb enhances MPTP neurotoxicity in mice","volume":"66","author":"Takahashi","year":"1989","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.neurol.2015.07.011_bib0405","article-title":"Combined exposure to agriculture pesticides, paraquat and maneb, induces alterations in the N\/OFQ-NOPr and PDYN\/KOPr systems in rats: relevance to sporadic Parkinson's disease","author":"Bastias-Candia","year":"2013","journal-title":"Environ Toxicol"},{"issue":"3","key":"10.1016\/j.neurol.2015.07.011_bib0410","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1074\/jbc.C100560200","article-title":"The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein","volume":"277","author":"Manning-Bog","year":"2002","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.neurol.2015.07.011_bib0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfm223","article-title":"Paraquat: the red herring of Parkinson's disease research","volume":"100","author":"Miller","year":"2007","journal-title":"Toxicol Sci"},{"issue":"12","key":"10.1016\/j.neurol.2015.07.011_bib0420","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat Neurosci"},{"issue":"Suppl. 2","key":"10.1016\/j.neurol.2015.07.011_bib0425","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S1353-8020(03)00023-3","article-title":"The rotenone model of Parkinson's disease: genes, environment and mitochondria","volume":"9","author":"Greenamyre","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"10.1016\/j.neurol.2015.07.011_bib0430","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson's disease","volume":"34","author":"Cannon","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.neurol.2015.07.011_bib0435","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.expneurol.2004.01.023","article-title":"Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone","volume":"187","author":"Fleming","year":"2004","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2015.07.011_bib0440","doi-asserted-by":"crossref","first-page":"e8762","DOI":"10.1371\/journal.pone.0008762","article-title":"Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice","volume":"5","author":"Pan-Montojo","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.neurol.2015.07.011_bib0445","doi-asserted-by":"crossref","first-page":"e 7878","DOI":"10.1371\/journal.pone.0007878","article-title":"Stereotaxical infusion of rotenone: a reliable rodent model for Parkinson's disease","volume":"4","author":"Xiong","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.neurol.2015.07.011_bib0450","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tips.2009.12.006","article-title":"Lessons from the rotenone model of Parkinson's disease","volume":"31","author":"Greenamyre","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neurol.2015.07.011_bib0455","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1749-6632.2009.04365.x","article-title":"Parkinson's disease: the dual hit theory revisited","volume":"1170","author":"Hawkes","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.neurol.2015.07.011_bib0460","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0376-8716(79)90076-0","article-title":"Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs","volume":"4","author":"Wagner","year":"1979","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.neurol.2015.07.011_bib0465","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0361-9230(85)90206-0","article-title":"Effects of chronic methamphetamine on the nigral-striatal dopamine system in rat brain: tyrosine hydroxylase immunochemistry and quantitative light microscopic studies","volume":"15","author":"Trulson","year":"1985","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neurol.2015.07.011_bib0470","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neuroscience.2011.05.046","article-title":"Impact of methamphetamine on dopamine neurons in primates is dependent on age: implications for development of Parkinson's disease","volume":"189","author":"Morrow","year":"2011","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.neurol.2015.07.011_bib0475","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12035-009-8064-1","article-title":"Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview","volume":"39","author":"Capela","year":"2009","journal-title":"Mol Neurobiol"},{"issue":"4","key":"10.1016\/j.neurol.2015.07.011_bib0480","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1471-4159.2008.05705.x","article-title":"Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice","volume":"107","author":"Granado","year":"2008","journal-title":"J Neurochem"},{"issue":"14","key":"10.1016\/j.neurol.2015.07.011_bib0485","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/mds.25646","article-title":"MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice","volume":"28","author":"Costa","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2015.07.011_bib0490","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awv183","article-title":"Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate","author":"Beaudoin-Gobert","year":"2015","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.neurol.2015.07.011_bib0495","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tig.2015.01.004","article-title":"Progress in unraveling the genetic etiology of Parkinson disease in a genomic era","volume":"31","author":"Verstraeten","year":"2015","journal-title":"Trends Genet"},{"issue":"1\u20134","key":"10.1016\/j.neurol.2015.07.011_bib0500","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000334285","article-title":"Update on genetics of parkinsonism","volume":"10","author":"Fujioka","year":"2012","journal-title":"Neurodegener Dis"},{"issue":"1","key":"10.1016\/j.neurol.2015.07.011_bib0505","doi-asserted-by":"crossref","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson's disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7\u20138","key":"10.1016\/j.neurol.2015.07.011_bib0510","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00335-011-9330-x","article-title":"Parkinson's disease mouse models in translational research","volume":"22","author":"Antony","year":"2011","journal-title":"Mamm Genome"},{"issue":"5","key":"10.1016\/j.neurol.2015.07.011_bib0515","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuron.2010.04.034","article-title":"Genetic animal models of Parkinson's disease","volume":"66","author":"Dawson","year":"2010","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neurol.2015.07.011_bib0520","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1471-4159.2009.06350.x","article-title":"Absence of nigral degeneration in aged parkin\/DJ-1\/PINK1 triple knockout mice","volume":"111","author":"Kitada","year":"2009","journal-title":"J Neurochem"},{"issue":"5321","key":"10.1016\/j.neurol.2015.07.011_bib0525","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.neurol.2015.07.011_bib0530","doi-asserted-by":"crossref","first-page":"292","DOI":"10.5607\/en.2014.23.4.292","article-title":"Alpha-synuclein function and dysfunction on cellular membranes","volume":"23","author":"Snead","year":"2014","journal-title":"Exp Neurobiol"},{"issue":"1","key":"10.1016\/j.neurol.2015.07.011_bib0535","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s13311-013-0234-1","article-title":"Animal models of Parkinson's disease: a gateway to therapeutics?","volume":"11","author":"Le","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.neurol.2015.07.011_bib0540","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice","volume":"209","author":"Luk","year":"2012","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.neurol.2015.07.011_bib0545","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bpa.12046","article-title":"Alpha-synuclein: the long distance runner","volume":"23","author":"George","year":"2013","journal-title":"Brain Pathol"},{"issue":"Suppl. 1","key":"10.1016\/j.neurol.2015.07.011_bib0550","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1002\/mds.22798","article-title":"The role of parkin in familial and sporadic Parkinson's disease","volume":"25","author":"Dawson","year":"2010","journal-title":"Mov Disord"},{"issue":"6676","key":"10.1016\/j.neurol.2015.07.011_bib0555","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neurol.2015.07.011_bib0560","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/ajmg.a.30157","article-title":"parkin mutation analysis in clinic patients with early-onset Parkinson [corrected] disease","volume":"129A","author":"Poorkaj","year":"2004","journal-title":"Am J Med Genet A"},{"issue":"6","key":"10.1016\/j.neurol.2015.07.011_bib0565","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1073\/pnas.0409598102","article-title":"Parkin-deficient mice are not a robust model of parkinsonism","volume":"102","author":"Perez","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.neurol.2015.07.011_bib0570","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1523\/JNEUROSCI.5351-08.2009","article-title":"Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein","volume":"29","author":"Lu","year":"2009","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.neurol.2015.07.011_bib0575","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1083\/jcb.201210111","article-title":"PINK1 drives Parkin self-association and HECT-like E3 activity upstream of mitochondrial binding","volume":"200","author":"Lazarou","year":"2013","journal-title":"J Cell Biol"},{"issue":"5674","key":"10.1016\/j.neurol.2015.07.011_bib0580","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"issue":"32","key":"10.1016\/j.neurol.2015.07.011_bib0585","doi-asserted-by":"crossref","first-page":"11364","DOI":"10.1073\/pnas.0802076105","article-title":"Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress","volume":"105","author":"Gautier","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.neurol.2015.07.011_bib0590","doi-asserted-by":"crossref","first-page":"e5777","DOI":"10.1371\/journal.pone.0005777","article-title":"Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration","volume":"4","author":"Gispert","year":"2009","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.neurol.2015.07.011_bib0595","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.neurobiolaging.2014.04.032","article-title":"Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice","volume":"35","author":"Oliveras-Salva","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2015.07.011_bib0600","doi-asserted-by":"crossref","first-page":"683920","DOI":"10.1155\/2013\/683920","article-title":"Neuroprotective function of DJ-1 in Parkinson's disease","volume":"2013","author":"Ariga","year":"2013","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"10.1016\/j.neurol.2015.07.011_bib0605","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1212\/01.WNL.0000113022.51739.88","article-title":"DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease","volume":"62","author":"Hedrich","year":"2004","journal-title":"Neurology"},{"issue":"5604","key":"10.1016\/j.neurol.2015.07.011_bib0610","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1126\/science.1077209","article-title":"Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism","volume":"299","author":"Bonifati","year":"2003","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.neurol.2015.07.011_bib0615","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuron.2005.01.041","article-title":"Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1","volume":"45","author":"Goldberg","year":"2005","journal-title":"Neuron"},{"issue":"14","key":"10.1016\/j.neurol.2015.07.011_bib0620","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1073\/pnas.0501282102","article-title":"Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress","volume":"102","author":"Kim","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.neurol.2015.07.011_bib0625","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1601-183X.2009.00559.x","article-title":"DJ-1-deficient mice show less TH-positive neurons in the ventral tegmental area and exhibit non-motoric behavioural impairments","volume":"9","author":"Pham","year":"2010","journal-title":"Genes Brain Behav"},{"issue":"39","key":"10.1016\/j.neurol.2015.07.011_bib0630","doi-asserted-by":"crossref","first-page":"15918","DOI":"10.1073\/pnas.1205102109","article-title":"Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease","volume":"109","author":"Rousseaux","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"51","key":"10.1016\/j.neurol.2015.07.011_bib0635","doi-asserted-by":"crossref","first-page":"18676","DOI":"10.1073\/pnas.0508052102","article-title":"Leucine-rich repeat kinase\u00a02 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration","volume":"102","author":"Smith","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.neurol.2015.07.011_bib0640","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","article-title":"Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology","volume":"44","author":"Zimprich","year":"2004","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.neurol.2015.07.011_bib0645","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurol"},{"issue":"9457","key":"10.1016\/j.neurol.2015.07.011_bib0650","first-page":"415","article-title":"A common LRRK2 mutation in idiopathic Parkinson's disease","volume":"365","author":"Gilks","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.neurol.2015.07.011_bib0655","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJMc055509","article-title":"LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews","volume":"354","author":"Ozelius","year":"2006","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.neurol.2015.07.011_bib0660","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1474-4422(08)70116-9","article-title":"LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study","volume":"7","author":"Hulihan","year":"2008","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2015.07.011_bib0665","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s13311-014-0284-z","article-title":"Heterogeneity of leucine-rich repeat kinase\u00a02 mutations: genetics, mechanisms and therapeutic implications","volume":"11","author":"Rudenko","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/j.neurol.2015.07.011_bib0670","doi-asserted-by":"crossref","first-page":"e18568","DOI":"10.1371\/journal.pone.0018568","article-title":"Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2","volume":"6","author":"Ramonet","year":"2011","journal-title":"PLoS One"},{"issue":"34","key":"10.1016\/j.neurol.2015.07.011_bib0675","doi-asserted-by":"crossref","first-page":"14622","DOI":"10.1073\/pnas.0906334106","article-title":"R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice","volume":"106","author":"Tong","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurol.2015.07.011_bib0680","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1750-1326-7-25","article-title":"LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors","volume":"7","author":"Hinkle","year":"2012","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.neurol.2015.07.011_bib0685","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fnana.2014.00155","article-title":"Parkinson's disease: animal models and dopaminergic cell vulnerability","volume":"8","author":"Blesa","year":"2014","journal-title":"Front Neuroanat"},{"issue":"7","key":"10.1016\/j.neurol.2015.07.011_bib0690","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nn.2349","article-title":"Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease","volume":"12","author":"Li","year":"2009","journal-title":"Nat Neurosci"},{"issue":"3","key":"10.1016\/j.neurol.2015.07.011_bib0695","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.nbd.2010.07.010","article-title":"Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice","volume":"40","author":"Melrose","year":"2010","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.neurol.2015.07.011_bib0700","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1523\/JNEUROSCI.5092-10.2011","article-title":"A rat model of progressive nigral neurodegeneration induced by the Parkinson's disease-associated G2019S mutation in LRRK2","volume":"31","author":"Dusonchet","year":"2011","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.neurol.2015.07.011_bib0705","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neuron.2012.05.018","article-title":"Sonic hedgehog maintains cellular and neurochemical homeostasis in the adult nigrostriatal circuit","volume":"75","author":"Gonzalez-Reyes","year":"2012","journal-title":"Neuron"},{"issue":"1\u20132","key":"10.1016\/j.neurol.2015.07.011_bib0710","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pneurobio.2005.09.001","article-title":"The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease","volume":"77","author":"Jankovic","year":"2005","journal-title":"Prog Neurobiol"},{"issue":"10","key":"10.1016\/j.neurol.2015.07.011_bib0715","first-page":"855","article-title":"The role of transcription factor Pitx3 in dopamine neuron development and Parkinson's disease","volume":"9","author":"Li","year":"2009","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"10.1016\/j.neurol.2015.07.011_bib0720","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1073\/pnas.0605208103","article-title":"Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons","volume":"104","author":"Ekstrand","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurol.2015.07.011_bib0725","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nbd.2014.01.011","article-title":"Progressive Parkinsonism by acute dysfunction of excitatory amino acid transporters in the rat substantia nigra","volume":"65","author":"Assous","year":"2014","journal-title":"Neurobiol Dis"},{"issue":"50","key":"10.1016\/j.neurol.2015.07.011_bib0730","doi-asserted-by":"crossref","first-page":"15923","DOI":"10.1523\/JNEUROSCI.3910-09.2009","article-title":"Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons","volume":"29","author":"Kadkhodaei","year":"2009","journal-title":"J Neurosci"},{"issue":"8","key":"10.1016\/j.neurol.2015.07.011_bib0735","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1523\/JNEUROSCI.3718-04.2005","article-title":"3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease","volume":"25","author":"Hwang","year":"2005","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.neurol.2015.07.011_bib0740","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.neurobiolaging.2009.02.015","article-title":"Association of transcription factor polymorphisms PITX3 and EN1 with Parkinson's disease","volume":"32","author":"Haubenberger","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2015.07.011_bib0745","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nbd.2014.09.012","article-title":"Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease","volume":"73","author":"Nordstrom","year":"2015","journal-title":"Neurobiol Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.neurol.2015.07.011_bib0750","first-page":"S107","article-title":"Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson's disease?","volume":"14","author":"Le","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2015.07.011_bib0755","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1146\/annurev.biochem.76.060305.152028","article-title":"DNA replication and transcription in mammalian mitochondria","volume":"76","author":"Falkenberg","year":"2007","journal-title":"Annu Rev Biochem"},{"issue":"Suppl. 3","key":"10.1016\/j.neurol.2015.07.011_bib0760","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/S1353-8020(09)70811-9","article-title":"The MitoPark Mouse \u2013 an animal model of Parkinson's disease with impaired respiratory chain function in dopamine neurons","volume":"15","author":"Ekstrand","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"10.1016\/j.neurol.2015.07.011_bib0765","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.bbadis.2008.09.009","article-title":"Targets for neuroprotection in Parkinson's disease","volume":"1792","author":"Yacoubian","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.neurol.2015.07.011_bib0770","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1471-4159.2007.05146.x","article-title":"Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunction","volume":"105","author":"Nafia","year":"2008","journal-title":"J Neurochem"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378715008048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378715008048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T12:21:03Z","timestamp":1748607663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378715008048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":154,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0035378715008048"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2015.07.011","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal models of Parkinson's disease: An updated overview","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2015.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}